In response to today’s announcement (Friday 24 February) by NHS England that it will routinely fund second stem cell transplants, Henny Braund, Chief Executive of Anthony Nolan says:
“We’re delighted with today’s announcement, which shows the voices of thousands of people, including patients, their families and their doctors, have been heard.
“Tragically, this decision comes too late for those patients who were denied the treatment that could have saved their lives. For others, this has been a source of huge anxiety and concern. For a patient who is undergoing a transplant, knowing that a second transplant is available should they relapse in the future will have a positive impact on their quality of life, both during and after treatment.”